Ann Clin Anesth Res | Volume 3, Issue 3 | Case Report | Open Access

Trigeminal Neuralgia; Chemical Ablation of Gasserian Ganglion Experience from Bangladesh

Chandra Shekhar Karmakar1*, Ashraful Hoque2, Lutfur Rahaman1 and ABM Muksudul Alam1

1Department of Anesthesia, ICU & Pain Medicine, Shaheed Suhrawardy Medical College Hospital, Bangladesh
2Center for Medical Biotechnology, MIS, DGHS, Bangladesh

*Correspondance to: Chandra Shekhar Karmakar 

Fulltext PDF


Trigeminal Neuralgia (TN) is painful one of the commonest cause of neurogenic fascial pain after 50 years of age. The pain can be described as a sudden, paroxysmal severe pain which is usually triggered by a non painful stimulus like touch, eating, drinking, washing and shaving or by any thermal changes. There is a lack of certainty regarding the aetiology and pathophysiology of
Trigeminal neuralgia. The treatment of this condition can be very challenging even the numerous options patients and physicians can choose from. This multitude of treatment options sometimes poses the question as to which treatment fits which patient best. For patients who are refractory to medical therapy multiple techniques such as Gasserian ganglion percutaneous techniques, gamma knife surgery and microvascular decompression are the most promising invasive treatment options. Among them some of the commonly performed interventions Pain physicians are doing frequently to provide pain relief are balloon compression, Glycerol rhizolysis and RF (Radio Frequency) rhizotomy. We report a case of a forty five years old female patient who presented with left sided lancinating pain in lower jaw for 3 years which was not relived by medication at all. Investigations and regular follow up has revealed classical trigeminal neuralgia pattern and percutaneous glycerol rhizolysis has been done in our centre with very good results.




Karmakar CS, Hoque A, Rahaman L, Muksudul Alam ABM. Trigeminal Neuralgia; Chemical Ablation of Gasserian Ganglion Experience from Bangladesh. Ann Clin Anesth Res. 2019;3(3):1027..

Subscribe to Our Newsletter